Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis

Table 1 Distribution of multi-drug resistance patterns among 43 fluoroquinolone-resistance E. coli isolates

No. of classes	Antimicrobial resistance class pattern	Frequency	Prevalence (%)
11	AMGs, BL/BLICs, CEPs, FQs, FPIs, MONs, PCNs, PHs, PPs, Qs, TETs	1	2.3
10	AMGs, BL/BLICs, CEPs, FQs, FPIs, MONs, PCNs, PHs, Qs, TETs	4	9.3
	AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, PPs, Qs, TETs	3	7.0
9	AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, Qs, TETs	16	37.2
	AMGs, BL/BLICs, FQs, FPIs, MONs, PCNs, PHs, Qs, TETs	1	2.3
8	AMGs, BL/BLICs, FQs, FPIs, PCNs, PHs, Qs, TETs	4	9.3
	AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, Qs, TETs	2	4.7
	AMGs, CEPs, FQs, PCNs, PHs, PPs, Qs, TETs	1	2.3
	AMGs, BL/BLICs, CEPs, FQs, FPIs, PCNs, PHs, Qs	1	2.3
7	AMGs, CEPs, FQs, MONs, PCNs, Qs, TETs	1	2.3
	AMGs, CEPs, FQs, PCNs, PHs, Qs, TETs	1	2.3
	AMGs, FQs, PCNs, PHs, PPs, Qs, TETs	1	2.3
6	AMGs, FQs, PCNs, PHs, Qs, TETs	6	14.0
	AMGs, CEPs, FQs, PCNs, Qs, TETs	1	2.3
	Total	43	100.0

AMGs Aminoglycosides, BL/BLICs β-lactam/β-lactamase inhibitor combinations, CEPs, Cephems, FQs Fluoroquinolones, FPIs Folate pathway inhibitors, MONs Monobactams, PCNs Penicillins, PHs, Phenicols, PPs Polypeptides, Qs Quionolones, TETs Tetracyclines

ISSN: 1471-2180